Triveni Enterpri (538569)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2.64 |
| Market Cap | ₹15.11 Cr |
| P/E Ratio | 0 |
| ROCE | 2.29% |
| ROE | -0.03% |
| Dividend Yield | 0% |
| Profit Growth | -90% |
| Debt/Equity | — |
| Sales Growth | -100% |
| 52-Week Range | ₹1 — ₹2.64 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹1.73 |
Strengths
- Book value of ₹1.73 per share provides a tangible asset base, implying roughly ₹9.8 crore of net assets against the ₹15 crore market cap.
- ROCE of 2.29% is positive, suggesting some capital employed is still generating a small operating return.
- Small market cap of ₹15 crore means any meaningful asset sale or business revival could have a disproportionate impact on per-share value.
Concerns
- Sales growth of -100% and latest quarter sales of ₹0 crore mean the core distribution business has effectively stopped generating revenue.
- Latest quarter net profit is ₹0 crore and profit growth is -90%, so there is no earnings power to support the valuation.
- P/B of 1.53 means the investor pays a 53% premium to book value, leaving no margin of safety in a no-earnings situation.
- Piotroski F-Score of 3/9, negative ROE of -0.03%, and zero dividend yield indicate weak fundamental health and no income return.
AI Analysis
Let me begin with the obvious: a company showing zero sales and zero net profit in the latest quarter is not a business in the normal sense. Triveni Enterpri trades at ₹2.64, giving a market cap of ₹15 crore, yet the book value is only ₹1.73 per share. So I am being asked to pay 1.53 times net assets for an entity with no turnover and no earnings. Graham would demand a discount to asset value, not a premium. The P/E of 0.00 is not cheapness; it simply tells you there is no E. Sales growth of -100% confirms distribution activity has disappeared. Profit growth of -90% and a negative ROE of -0.03% underline how little economic value this shell is currently producing. ROCE of 2.29% is barely above zero, and with a Piotroski F-Score of 3 out of 9, the financial health is weak. There is zero dividend, so the only possible return is from someone else paying a higher price — that is speculation, not investment. I cannot call this a great company, a growing company, or a company with a moat. At best, it is an asset situation: ₹1.73 per share of book value, but the price already sits above that. My margin of safety is negative. The 52-week range of ₹1.00 to ₹2.64 shows the stock has moved up sharply, but that is market sentiment, not business performance. I would not buy hope. I would wait for a much lower price — well below book value — or evidence that sales and profits are genuinely returning. Until then, this belongs in the 'too hard' pile.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer